GSK fails in purple inhaler passing off claim against Sandoz and Vectura (...and breathe) - The IPKat
Fluticasone & Salmeterol Inhaler, 1 Accuhaler, GSK
GSK recalls 600000 Ventolin Inhalers from US
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
Adherium wins US clearance for GSK inhaler users to connect to new platform
RECALL: Ventolin Diskus inhalers - Today's Parent
GSK, Propeller 'smart inhaler' gets FDA green light | Fierce Biotech
GSK seeks additional asthma indication for Trelegy Ellipta - MassDevice
ADVAIR homepage | ADVAIR (fluticasone propionate and salmeterol)
Ventorlin CFC Free Inhaler 100 Mcg/18 Mg | Salbutamol | Albuterol
GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients | Fierce Pharma
GSK opens £56m Ellipta inhaler plant in the UK
GSK pumping out millions more Ellipta inhalers with new U.K. plant | Fierce Pharma
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy
Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler ( GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
GSK confirms therapeutic efficacy of COPD triple-therapy inhaler < Pharma < Article - KBR
New GLAXOSMITHKLINE Trelegy Ellipta fluticasone/umeclidinium/vilanterol Disposables - General For Sale - DOTmed Listing #4731119:
Propeller Health to Develop Sensor for GSK Ellipta Inhaler | RT
New Strength of Trelegy Ellipta Inhaler Available to Treat Asthma In Canada | CanadaDrugstore
GSK Starts Phase III Study of Therapy for Patients with Asthma - Drug Discovery and Development
Can Switching Inhalers Reduce Your Carbon Footprint? | MedPage Today
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy
CHONBURI, THAILAND-JANUARY 31, 2021 : Symbicort, Avamys, Seretide, Ventolin, with tablets pills and bottle on blue background. Asthma and COPD inhaler. GlaxoSmithKline (GSK) and Astrazenaca products. Stock Photo | Adobe Stock
GSK breathes freely as Mylan launches Advair generic in UK
FDA Approves Combination Inhaler for COPD - MPR
Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die - Bloomberg
